It looks like they’re still on the hunt for cash.
You are Invited to Attend an Online Presentation: The Histogen Investment Opportunity
As a friend of Histogen, you may be aware that the Company is currently seeking to close its Series A financing to begin a pivotal clinical trial of the Hair Stimulating Complex (HSC). Due to the large number of inquires we have received following the announcement of our preliminary clinical trial results (which showed statistical significance at three efficacy endpoints), we will be presenting the trial data and investment opportunity in an online setting for the first time.
We appreciate the opportunity to share our story, and look forward to connecting with you in this casual online setting! We hope you will assist us by sharing this invitation with those you feel may be interested!
Wednesday, October 7th, 4:00-4:30pm PT/7:00-7:30pm ET
Histogen CEO Gail K. Naughton, Ph.D., will present:
· An overview of Histogen’s technology and product portfolio
· Results of the preliminary clinical trial of HSC for hair regrowth
· Plans for future trials and market introductions
· An introduction to the Series A investment opportunity
As space is limited, please RSVP to Eileen Naughton Brandt at email@example.com with the date of the presentation you will be attending.
Thank you, and we look forward to connecting with you soon